The Role of Crosstalk between AR3 and E2F1 in Drug Resistance in Prostate Cancer Cells
Background: Drug resistance is one of the most prevalent causes of death in advanced prostate cancer patients. Combination therapies that target cancer cells via different mechanisms to overcome resistance have gained increased attention in recent years. However, the optimal drug combinations and th...
Main Authors: | Jin Xu, Xi Yang, Dhanraj Deshmukh, Hegang Chen, Shengyun Fang, Yun Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1094 |
Similar Items
-
Regulation of androgen receptor variants in prostate cancer
by: Yezi Zhu, et al.
Published: (2020-07-01) -
Knowledge structure and emerging trends of AR
variants in prostate cancer: a bibliometric analysis
based on CiteSpace and VOSviewer
by: Kai Yu, et al.
Published: (2023-07-01) -
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
by: Neele Wüstmann, et al.
Published: (2023-04-01) -
The association of AR-V7 with resistance to Abiraterone in metastatic castration-resistant prostate cancer
by: Shuo Wang, et al.
Published: (2022-03-01) -
AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption
by: Navid Sobhani, et al.
Published: (2021-05-01)